A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: A Cancer Research Campaign trial

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1563-1568

  James, L E ^a   Gower, N H ^b   Rudd, R M ^b   Spiro, S G ^a   Harper, P G ^c   Trask, C W ^d   Partridge, M ^e   Ruiz De Elvira, M C ^a   Souhami, R L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d SOUTHEND HOSPITAL   (United Kingdom)

^e WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Palliation; Small cell lung cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; ONDANSETRON; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOXICITY; FEMALE; HEMATURIA; HUMAN; HUMAN CELL; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; NEUROPATHY; ORAL DRUG ADMINISTRATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0030058430     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.295     Document Type: Article

References (24)

1. BYRNE A AND CARNEY DN. (1994). Small cell lung cancer in the elderly. Semin. Oncol., 21 (suppl. 6), 43-48.
2. CARNEY DN AND BYRNE A. (1994). Chemotherapy for the elderly or unfit patient with small cell lung cancer. Lung Cancer, 11, 140-141.
3. CARNEY DN, GROGAN L, SMIT EF, HARFORD P, BERENDSEN HA AND POSTMUS PE. (1990). Single-agent oral etoposide for elderly small cell lung cancer patients. Semin. Oncol., 17, 49-53.
4. CLARK A AND FALLOWFIELD LJ. (1986). Quality of life measurements in patients with malignant disease: a review. J. R. Soc. Med., 79, 165-169.
5. COMIS RL. (1993). Extensive small cell lung cancer. Lung Cancer, 9(suppl. 1), S27-S39.
6. EARL HM, RUDD RM, SPIRO SG, ASH CM, JAMES LE, LAW CS, TOBIAS JS, HARPER PG, GEDDES DM, ERAUT D, PARTRIDGE MR AND SOUHAMI RL. (1991). A randomised trial of planned versus as required chemotherapy in small cell lung cancer: A Cancer Research Campaign trial. Br. J. Cancer, 64, 566-572.
7. FAYERS PM, BLEEHEN NM, GIRLING DJ AND STEPHENS RJ. (1991). Assessment of quality of life in small-cell lung cancer using a daily diary card developed by the Medical Research Council Lung Cancer Working Party. Br. J. Cancer, 64, 299-306.
8. FELD R, EVANS WK, COY P, HODSON I, MACDONALD AS, OSOBA D, PAYNE D, SHELLEY W AND PATER JL. (1987). Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J. Clin. Oncol, 5, 1401-1409.
9. FIGUEREDO AT, HRYNIUK WM, STRAUTMANIS I, FRANK G AND RENDELL S. (1985). Co-trimoxazole prophylaxis during high-dose chemotherapy of small cell lung cancer. J. Clin. Oncol., 3, 54-64.
10. GEDDES DM, DONES L, HILL E, LAW K, HARPER PG, SPIRO SG, TOBIAS JS AND SOUHAMI RL. (1990). Quality of life during chemotherapy for small cell lung cancer: Assessment and use of a daily diary card in a randomized trial. Eur. J. Cancer, 26, 484-492.
11. HAYBITTLE JL. (1979). The reporting of non-significant results in clinical trials. In Clinical Trials in Early Breast Cancer, Scherulen H R, Weckesser G, Armbruster I. (eds), Springer: Berlin.
12. HRYNIUK WM. (1988). The importance of dose intensity in the outcome of chemotherapy. In Important Adv. Oncol., De Vita VT Jnr, Hellman S and Rosenberg SA. (eds.) pp. 121-141. Lippincott: Philadelphia.
13. IHDE DC, MULSHINE JL, KRAMER BS, STEINBERG SM, LINNOILA RI, GAZDAR AF, EDISON M, PHELPS RM, LESAR M, PHARES JC, GRAYSON J, MINNA JD AND JOHNSON BE. (1994). Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J. Clin. Oncol., 12, 2022-2034.
14. KLASA RJ, MURRAY N AND COLDMAN AJ. (1991). Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J. Clin. Oncol., 9, 499-508.
15. MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY. (1993). A randomised trial of three or six courses of etoposide, cyclophosphamide, methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC) I: survival and prognostic factors. Br. J. Cancer, 68, 1150-1156.
16. MILES DW, EARL HM, SOUHAMI RL, HARPER PG, RUDD R, ASH CM, JAMES L, TOBIAS JS AND SPIRO SG. (1991). Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer. J. Clin. Oncol., 9, 280-285.
17. PETO R, PIKE MC, ARMITAGE P, BRESLOW NE, COX DR, HOWARD SV, MANTEL N, MCPHERSON K, PETO J AND SMITH PG. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br. J. Cancer, 35, 1-39.
18. RAWSON NSB AND PETO J. (1990). An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the UKCCCR. Br. J. Cancer, 61, 597-604.
19. SCULIER JP, PAESMANS M, BUREAU G, DABOUIS G, LIBERT P, VANDERMOTEN G, VAN CUTSEM O, BERCHIER MC, RIES F AND MICHEL J. (1993). Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: A phase III randomized study conducted by the European Lung Cancer Working Party. J. Clin. Oncol., 11, 1858-1865.
20. SLEVIN ML, PLANT H, LYNCH D, DRINKWATER J AND GREGORY WM. (1988). Who should measure quality of life, the doctor or the patient? Br. J. Cancer, 57, 109-12.
21. SOUHAMI RL AND LAW K. (1990). Longevity in small cell lung cancer. Br. J. Cancer. 61, 584-589.
22. SOUHAMI RL, BRADBURY I, GEDDES DM, SPIRO SG, HARPER PG AND TOBIAS JS. (1985). Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res., 45, 2878-2882.
23. SOUHAMI RL, RUDD R, RUIZ DE ELVIRA M-C, JAMES L, GOWER N, HARPER PG, TOBIAS JS, PARTRIDGE MR, DAVISON AG, TRASK C AND SPIRO SG. (1994). Randomised trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: A Cancer Research Campaign Trial. J. Clin. Oncol., 12, 1806-1813.
24. TANNOCK IF, BOYD NF, DE BOER G, ERLICHMAN C, FINE S, LAROCQUE G, MAYERS C, PERRAULT D AND SUTHERLAND H. (1987). A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J. Clin. Oncol., 6, 1377-1387.